poisar

Stocks · News reference

FDA Conditionally Accepts Acurx Pharmaceuticals' Brand Name CIFBEZY for Ibezapolstat

BenzingaAug 17, 2026, 12:09 PMBenzinga Newsdesk

The proposed proprietary name, or brand name, CIFBEZY has received conditional acceptance from the FDA and also federal trademark allowance from the USPTOThese initial milestones will form the basis for the commercial

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 17, 2026, 12:09 PM
Checked
Aug 17, 2026, 12:09 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading